ISSN: 0304-128X ISSN: 2233-9558
Copyright © 2024 KICHE. All rights reserved

Articles & Issues

Language
english
Conflict of Interest
In relation to this article, we declare that there is no conflict of interest.
Publication history
Received February 21, 2015
Accepted June 9, 2015
articles This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.

All issues

In-vitro Anticancer and Antioxidant Activity of Gold Nanoparticles Conjugate with Tabernaemontana divaricata flower SMs Against MCF -7 Breast Cancer Cells

1Department of Plant Biology and Biotechnology, PG Biotechnology, Loyola College, Chennai-600 034.Tamil Nadu, India 2Helen Keller Research Centre, Loyola College, Chennai, Tamil Nadu, India
preetamraj.jp@gmail.com
Korean Chemical Engineering Research, February 2016, 54(1), 75-80(6), 10.9713/kcer.2016.54.1.75 Epub 12 February 2016
downloadDownload PDF

Abstract

Biologically stabilized gold nanoparticles were synthesized from the flower aqueous extract of T. divaricata. The synthesized nanoparticles were characterized by UV-Vis spectrophotometer, Zeta sizer, FTIR and TEM analysis. T. divaricata reduced gold nanoparticles having particle size and potential of 106.532 nm and -10.2 mV, respectively, with a characteristic peak of 550 nm in UV-visible spectrophotometer. FTIR graph after comparison between the crude flower extract and gold nanoparticles showed three major shifts in the functional groups. The morphology and size of the gold nanoparticles were examined by HRTEM analysis, which showed that most of the nanoparticles were nearly spherical with size of 100 nm. The gold nanoparticles synthesized demonstrated potent anticancer activity against MCF-7 cell line. The findings conclude that the antioxidant molecule present in T. divaricata may be responsible for both reduction and capping of gold nanoparticles which possess potential applications in medicine and pharmaceutical fields.

References

Ma X, Yu H, J. Bio. Med., 79(3), 85 (2006)
Tanih NF, Ndip RN, J. Scientific World, 7 (2013)
Amruthraj NJ, Preetam Raj JP, Lebel A, Appl. Nanoscience, 5, 403 (2015)
Yang HC, Hon MH, J. Microchem., 92, 87 (2009)
Huo Q, Colloids Surf. B: Biointerfaces, 59, 1 (2007)
Song JY, Kim B, Bioprocess. Biosyst. Eng., 32, 79 (2008)
Kumar V, Yadav SC, Yadav SK, J. Chem. Technol. Biotechnol., 85(10), 1301 (2010)
Singh B, Sharma RA, Vyas GK, Br., 125-132(2013).
Abel EE, John Poonga PR, Panicker S, Appl Nanosci (2015)
Mossman TJ, J. Immunol. Methods, 64, 55 (1983)
Sinha KA, Anal. Biochem., 47, 389 (1972)
Ebrahimzadeh MA, Nabavi SF, Nabavi SM, Pharmacol., 2, 1097 (2009)
Rio DD, Pellegrini N, Colombi B, Bianchi M, Serafini M, Torta F, Tegoni M, Musci M, Brighenti F, Clin Chem., 49, 690 (2003)
Abeer S, IMSA., 25(3) (2012)
Buzea C, Ivan I, Blandino P, Bobbie K, Biointerphases., 2(4), MR17-MR172(2007).
Basavegowda N, Kupiec A, Malina D, Yathirajan HS, Keerthi VR, Chandrasekar N, Dinkar S, Liny P, Adv. Mater. Lett., 4, 332 (2013)
Elavazhagan T, Arunachalam KD, Int. J. Nanomed., 6, 1265 (2011)
Rajesh WK, Jaya RL, Niranjan SK, Vijay DM, Sahebrao BK, Curr. Nanosci., 5, 117 (2009)
Ankamwar B, Damle C, Ahmed A, Sastry M, J. Nanosci. Nanotechnol., 5, 1665 (2005)
Sivakumar P, Nethradevi C, Renganathan S, Asian J. Pharm. Clin. Red., 5(4), 97 (2012)
Poornima K, Gopalakrishnan VK, Chin. J. Biology, 1(2), 1 (2012)

The Korean Institute of Chemical Engineers. F5, 119, Anam-ro, Seongbuk-gu, 233 Spring Street Seoul 02856, South Korea.
Phone No. +82-2-458-3078FAX No. +82-507-804-0669E-mail : kiche@kiche.or.kr

Copyright (C) KICHE.all rights reserved.

- Korean Chemical Engineering Research 상단으로